Modelling phytoplankton development in whole drainage networks: the RIVERSTRAHLER Model applied to the Seine river system

Phytoplankton development in river systems is under the control of various meteorological, hydrological, chemical and biological factors. Because of the continuity of the aquatic systems which progress from headwaters to the largest rivers, the interplay of these control factors can only be understood at the scale of the entire drainage network. The RIVERSTRAHLER Model, based on the concept of stream-order, has been established for that purpose. It has been applied here on two rivers from the Seine basin: rivers Marne and Oise. It is shown that hydrological factors determine the time of onset, and the position within the drainage network, of the spring algal bloom. Phosphorus availability, when limiting, controls the intensity of the bloom. During summer, top-down control, linked to grazing and other causes of mortality, has a marked impact on algal dynamics. © 1994 Kluwer Academic Publishers.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Algarde-Oise: Un modèle opérationnel pour la prédiction des variations de qualité des eaux lors d'efflorescences algales

info:eu-repo/semantics/publishe

Influence of hemodialysis on pramipexole pharmacokinetics: lessons from two cases and literature review

BACKGROUND: Restless legs syndrome (RLS) is not a rare condition in patients on long-term dialysis. Pramipexole is a small molecule used in the treatment of idiopathic and uremic RLS. Although some information concerning the efficacy and safety of pramipexole in uremic patients is available, data concerning the pharmacokinetics of pramipexole in hemodialysis (HD) are lacking. Following the occurrence of accidental pramipexole intoxication in a chronic HD patient, we were concerned about the efficacy of HD in removing pramipexole. Our aim was thus to assess plasma pramipexole concentrations and pramipexole clearance in a stable chronic HD patient without any residual kidney function. MATERIALS AND METHODS: Our patient was a 63-year-old man on chronic HD for 5 years who had been treated uneventfully with oral pramipexole for uremic RLS since then. During a routine 4-hour high-flux HD session, blood, ultrafiltrate, and dialysate samples were collected every hour to determine pramipexole concentrations over time. RESULTS: Pramipexole blood concentrations ranged from 12.1 to 23.9 µg/L. Pramipexole reduction ratio was 32.5%. Mean dialytic clearance of pramipexole was 76.8 mL/min. Postdialysis rebound was 5.6%. CONCLUSION: In the absence of any side effect, pramipexole blood concentrations at steady state were 2- to 4-fold higher than those observed in subjects with normal kidney function. Like other drugs with a high volume of distribution, pramipexole was poorly removed by HD. Therefore, HD is not recommended as a treatment option for pramipexole intoxication in patients with a glomerular filtration rate superior to 30 mL/min/1.73m²

Eutrophisation de la Marne: Etat 1991

Rapport final (1ère phase)info:eu-repo/semantics/publishe